1. Emadi MS, Soltani S, Noori B, Zandi M, Shateri Z, Tabibzadeh A, Behboudi E, Erfani Y, Tabaeian SP, Pourhossein B, Didehdar M. Highly conserve sequences in envelope, nucleoprotein and RNA-dependent RNA polymerase of SARS-CoV-2 in nasopharyngeal samples of the COVID-19 patients; a diagnostic target for further studies. Journal of Cellular & Molecular Anesthesia 2022;7:78-83
2. Zandi M, Behboudi E, Shojaei MR, Karami H. Letter to the editor regarding" an overview on serology and molecular tests for COVID-19: an important challenge of the current century (doi: 10.22034/iji.2021.88660.1894.)". Iranian Journal of Immunology 2022;19:337
3. Behboudi E, Hamidi V, Gholizadeh F, Grala EM, Ghelmani Y, Nakhaie M, Charostad J, Astani A. Association between ABO blood groups and rhesus antigen and susceptibility to COVID-19 in the Yazd hospital. New Microbes and New Infections 2021;44:100934 [
DOI:10.1016/j.nmni.2021.100934]
4. Zandi M, Behboudi E, Soltani S. Role of glycoprotein hemagglutinin-esterase in COVID-19 pathophysiology?. Stem Cell Reviews and Reports 2021;17:2359-60 [
DOI:10.1007/s12015-021-10210-1]
5. Behboudi E, Mokhtari-Azad T, Yavarian J, Ghavami N, Khorrami SM, Rezaei F, Charostad J, Malekshahi SS, Shafiei-Jandaghi NZ. Molecular detection of HHV1-5, AAV and HPV in semen specimens and their impact on male fertility. Human Fertility 2019;22:133-8 [
DOI:10.1080/14647273.2018.1463570]
6. Esfahanian N, Shirvani F, Bazgir N, Karimi A, Tabatabaei SR, Armin S, Fahimzad SA, Ghanaiee RM, Esfahanian Y. Investigation of Clinical Manifestations and Laboratory Findings of COVID-19 During National Peaks of Alpha, Beta, Delta, and Omicron in the Pediatric Emergency Department of Mofid Children's Hospital, Tehran, Iran. Archives of Pediatric Infectious Diseases 2023 [In Press] [
DOI:10.5812/pedinfect-134554]
7. Dyer O. Covid-19: Omicron is causing more infections but fewer hospital admissions than delta, South African data show. BMJ 2021;375:n3104 [
DOI:10.1136/bmj.n3104]
8. Cloete J, Kruger A, Masha M, du Plessis NM, Mawela D, Tshukudu M, et al. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study. The Lancet Child & Adolescent Health 2022;6:294-302 [
DOI:10.1016/S2352-4642(22)00027-X]
9. Christophers B, Gallo Marin B, Oliva R, Powell WT, Savage TJ, Michelow IC. Trends in clinical presentation of children with COVID-19: a systematic review of individual participant data. Pediatric Research 2022;91:494-501 [
DOI:10.1038/s41390-020-01161-3]
10. Vitiello A, Ferrara F, Auti AM, Di Domenico M, Boccellino M. Advances in the Omicron variant development. Journal of Internal Medicine 2022;292:81-90 [
DOI:10.1111/joim.13478]
11. Zandi M, Hosseini F, Adli AH, Salmanzadeh S, Behboudi E, Halvaei P, Khosravi A, Abbasi S. State-of-the-art cerium nanoparticles as promising agents against human viral infections. Biomedicine & Pharmacotherapy 2022;156:113868 [
DOI:10.1016/j.biopha.2022.113868]
12. Sahebi S, Keikha M. Clinical features of SARS-CoV-2 Omicron BA. 2; Lessons from previous observations-correspondence. International Journal of Surgery (London England) 2022;104:106754 [
DOI:10.1016/j.ijsu.2022.106754]